A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors

Signal Transduct Target Ther. 2022 Jan 13;7(1):15. doi: 10.1038/s41392-022-00875-6.

Svenja Mergener^{1

2}, Samuel Peña-Llopis^{3

4}

¹ Translational Genomics in Solid Tumors, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) at University Hospital Essen, Hufelandstrasse 55, D-45147, Essen, Germany.
² Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany.
³ Translational Genomics in Solid Tumors, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) at University Hospital Essen, Hufelandstrasse 55, D-45147, Essen, Germany. Samuel.Pena-Llopis@dkfz.de.
⁴ Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany. Samuel.Pena-Llopis@dkfz.de.

No abstract available

Publication types